Lonza Group Ag Price to Book Ratio 2012-2023 | LZAGY
Historical price to book ratio values for Lonza Group Ag (LZAGY) over the last 10 years. The current price to book ratio for Lonza Group Ag as of May 07, 2024 is 4.03.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Lonza Group Ag Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
0.00 | nan |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $42.715B | $7.478B |
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $184.697B | 24.18 |
Stryker (SYK) | United States | $126.529B | 30.31 |
Medtronic (MDT) | Ireland | $108.749B | 15.40 |
Boston Scientific (BSX) | United States | $107.729B | 34.31 |
EssilorLuxottica (ESLOY) | France | $100.445B | 0.00 |
Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
ResMed (RMD) | United States | $31.755B | 29.82 |
Terumo (TRUMY) | Japan | $25.536B | 36.06 |
Zimmer Biomet Holdings (ZBH) | United States | $24.982B | 15.96 |
Koninklijke Philips (PHG) | Netherlands | $24.619B | 19.07 |
Baxter (BAX) | United States | $18.406B | 13.09 |
Insulet (PODD) | United States | $12.904B | 67.75 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.899B | 0.00 |
Demant (WILYY) | Denmark | $10.100B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.983B | 26.11 |
BellRing Brands (BRBR) | United States | $7.654B | 35.85 |
Lantheus Holdings (LNTH) | United States | $5.268B | 13.13 |
Haemonetics (HAE) | United States | $4.835B | 24.73 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.086B | 12.46 |
Prestige Consumer Healthcare (PBH) | United States | $3.472B | 16.42 |
Envista Holdings (NVST) | United States | $3.265B | 13.48 |
QuidelOrtho (QDEL) | United States | $2.935B | 10.65 |
Neogen (NEOG) | United States | $2.688B | 25.85 |
TG Therapeutics (TGTX) | United States | $2.655B | 74.70 |
Green Thumb Industries (GTBIF) | United States | $2.552B | 80.87 |
ICU Medical (ICUI) | United States | $2.480B | 21.89 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.253B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.862B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.704B | 49.93 |
Verano Holdings (VRNOF) | United States | $1.704B | 0.00 |
InMode (INMD) | Israel | $1.554B | 8.26 |
Owens & Minor (OMI) | United States | $1.447B | 12.61 |
National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
AdaptHealth (AHCO) | United States | $1.297B | 9.66 |
Warby Parker (WRBY) | United States | $1.255B | 0.00 |
AtriCure (ATRC) | United States | $1.041B | 0.00 |
MacroGenics (MGNX) | United States | $1.004B | 0.00 |
Canopy Growth (CGC) | Canada | $0.960B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.843B | 0.00 |
Evolus (EOLS) | United States | $0.840B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.679B | 14.71 |
Quanterix (QTRX) | United States | $0.664B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.648B | 15.24 |
Valneva SE (VALN) | France | $0.522B | 0.00 |
PetIQ (PETQ) | United States | $0.517B | 19.32 |
Jin Medical (ZJYL) | China | $0.504B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
Surmodics (SRDX) | United States | $0.454B | 28.45 |
ZimVie (ZIMV) | United States | $0.437B | 26.75 |
Biote (BTMD) | United States | $0.430B | 8.24 |
OraSure Technologies (OSUR) | United States | $0.424B | 7.01 |
Aurora Cannabis (ACB) | Canada | $0.363B | 0.00 |
Zynex (ZYXI) | United States | $0.348B | 47.56 |
Cerus (CERS) | United States | $0.342B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.297B | 29.46 |
Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.249B | 15.44 |
Veru (VERU) | United States | $0.239B | 0.00 |
Omeros (OMER) | United States | $0.211B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.186B | 0.00 |
High Tide (HITI) | Canada | $0.174B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.172B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.171B | 0.00 |
InterCure (INCR) | Israel | $0.147B | 24.77 |
Eagleford Energy (GRUSF) | United States | $0.135B | 68.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.47 |
Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
MariMed (MRMD) | United States | $0.111B | 0.00 |
Fonar (FONR) | United States | $0.109B | 9.32 |
Brainsway (BWAY) | Israel | $0.101B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.099B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Chimerix (CMRX) | United States | $0.089B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Safety Shot (SHOT) | United States | $0.063B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.20 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |